trending Market Intelligence /marketintelligence/en/news-insights/trending/8R8bSxjsDjC3rjj9F66K4g2 content esgSubNav
In This List

Rigel Pharmaceuticals prices common stock offering

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Rigel Pharmaceuticals prices common stock offering

Rigel Pharmaceuticals Inc. priced an underwritten public offering of 18,100,000 common shares at $3.35 apiece to raise about $60.6 million in gross proceeds.

The company granted underwriters a 30-day option to buy up to an additional 2,715,000 common shares at the offering price.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Jefferies LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering, with H.C. Wainwright & Co. LLC as lead manager.